Video

Jing Cui, PhD: Identifying Risk Factors for Systemic Lupus Erythematosus

Author(s):

Research presented by Dr. Jing Cui at ACR 2021 Convergence identified significant risk factors for systemic lupus erythematosus in a risk prediction model study.

A study presented at the American College of Rheumatology 2021 Convergence by Jing Cui, PhD, Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School assessed risk prediction models incident systemic lupus erythematosus (SLE) using lifestyle and environmental risk factors as well as a genetic risk score.

Lifestyle and environmental factors and weighted genetic risk score were concluded to classify future systemic lupus erythematosus risk with good AUC of 0.721. According to the study, this is the first SLE prediction model that used environmental and genetic factors and might be easily employed in at-risk populations.

Individuals who are identified as high-risk at a pre-disease stage can reduce the long-term impact of systemic lupus erythematosus on quality of life and morbidity, Cui explained.

By identifying risk factors and genetic factors, investigators aimed to develop a risk prediction model in order to identify individuals with high-risk as early as possible.

Results showed that genetic factors, obesity, and a young age of menarche (less than 10 years) were the most impactful factors in assessing risk of systemic lupus erythematosus.

"In the long run," Cui said, "we were trying to identify the high-risk population and maybe delay their lupus onset or they can have less severe stage of disease."

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.